X0707 D LIVE 0001137883 BRAINSTORM CELL THERAPEUTICS INC. 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 646-666-3188 DELAWARE Golden Hand Resources Inc. BRAINSTORM CELL THERAPEUTICS INC GOLDEN HAND RESOURCES INC WIZBANG TECHNOLOGIES INC Corporation true Liat Sossover 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Chen Schor 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Robert Shorr 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Irit Arbel 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Alon Pinkas 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Malcolm S. Taub 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Mordechai Friedman 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Director Chaim Lebovits 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Anthony Fiorino 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Uri Yablonka 605 THIRD AVENUE 34TH FLOOR NEW YORK NY NEW YORK 10158 Executive Officer Director Biotechnology Decline to Disclose 06b false 2014-06-19 false true true true false 0 Maxim Group LLC 120708 Maxim Group LLC 120708 405 LEXINGTON AVE. NEW YORK NY NEW YORK 10174 All States false 10500000 10500000 0 false 11 724500 0 In addition to payment of cash consideration, the Issuer will issue to Maxim Group LLC a 3-year warrant to purchase up to 1,260,000 shares of Common Stock, with an exercise price equal to $0.30. 0 true BRAINSTORM CELL THERAPEUTICS INC. /s/ Anthony Fiorino Anthony Fiorino Chief Executive Officer 2014-06-30